- Feb. 13, 2013 - DULUTH, Ga. --
SINGAPORE - MediPurpose™
, a master distributor and manufacturer of medical devices
, today announced that TÜV Rheinland NA has recertified the company under CAN/ISO 13485.
The recertification verifies that MediPurpose’
s quality management systems (QMS) meet the requirements of the international standard ISO 13485 and the Canadian Medical Device Regulations (CMDR).
CAN/CSA-ISO 13485 assessments and certification must be performed by Canadian Medical Devices Conformity Assessment System (CMDCAS) recognized registrars.
MediPurpose founder and CEO Patrick Yi said, “With this recertification, MediPurpose can now apply for the renewal of the babyLance™ infant heelsticks
and SurgiLance™ safety lancet
medical device licenses from Health Canada.”For more information about MediPurpose’s medical products—including requests for no-cost samples—please visit www.medipurpose.com/products
Founded in 1999, MediPurpose is an innovative medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance™ heel incision device (http://medipurpose.com/
babylance), SurgiLance™ safety lancet (http://www.medipurpose.com/
surgilance/) and MediPlus™ advanced wound care products (http:///www.medipurpose.com/
mediplus), MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors (http://www.medipurpose.com/
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors (http://www.medipurpose.com/
innovation/) and innovative medical product companies (http://www.medipurpose.com/
innovation/) that seek entrance into new medical device markets.
For more information about MediPurpose’
s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit www.medipurpose.com.